Alkermes Q4 Adjusted EPS $0.48 Misses $0.51 Estimate, Sales $377.48M Beat $362.02M Estimate
Portfolio Pulse from Benzinga Newsdesk
Alkermes reported Q4 adjusted EPS of $0.48, missing the $0.51 estimate, but its sales of $377.48M exceeded the $362.02M estimate. This represents a 20% increase in earnings and a 23.89% increase in sales from the same period last year.
February 15, 2024 | 12:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Alkermes Q4 earnings report showed a miss on EPS estimates but exceeded sales forecasts, indicating mixed financial performance.
The miss on the EPS estimate may concern some investors, potentially putting downward pressure on the stock. However, the significant beat on sales and year-over-year growth could counterbalance this by signaling strong operational performance and market demand for Alkermes' products. The mixed results make the short-term impact on the stock price uncertain, hence a neutral score.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100